The 5th Kyoto University LifeScience Showcase @ San Diego 2024 with AI-MAILs
February 26, 2024 1:00-4:30pm (PST)
Roth Auditorium at Sanford Consortium for Regenerative Medicine
2880 Torrey Pines Scenic Drive, La Jolla, CA 92037
LIVE streaming available(US domestic only)
Start-ups stemming from academia who have state-of-the-art innovations with solid science and technologies will participate the event, and present their novel technologies and seeds in the life science fields including pharmaceuticals, regenerative medicine, medical devices, and diagnostics. Participants who are interested in investing on medical area innovations will be welcomed.
Registration fee : Free
contact : info@kurcsd.com
Program
* 5 minutes for presentation, 8 minutes for comments & Q/A .
* The program is subject to change.
1:00pm(PST) Showcase pitch event
Session1 "Cell Therapy & Gene Therapy"
Session2 "Medical Device, Diagnosis & AI"
Session3 "Small Molecule & Biologics"
4:30pm(PST) Networking & reception
6:00pm(PST) Adjourn
Presenters
The detailed program will be announced later.
"Skin Image Analysis of AquaAge Inc."
AquaAge Inc.
naren.bao@aquaage.ai
"AI-Powered Organ-Specific Clinical Solutions and Hyper-Efficient Deep Data Chips"
EverFortune.AI
yvanie.lin@everfortuneai.com.tw
"Allogenic cell therapy for solid tumors: An innovative CAR-T strategy"
"First-in-Human Pilot Trial of Combined Intracoronary and Intravenous Mesenchymal stem Cell Therapy in Acute Myocardial Infarction"
Ever Supreme Bio Technology
service@ever-supreme.com.tw
"Gene therapy for the treatment of glaucoma."
Eyegenex, Inc
prasad@eyegenex.com
"World’s 1st Ferroptosis inducing Anti-cancer therapeutics"
FeropptoCure Inc.
yotsuki@ferroptocure.com
"Our orphan-drug designated pulmonary fibrosis therapeutic candidate, HL001"
HiLung Inc.
contact@hilung.com
"Multidisciplinary discussion (MDD) Diagnosis system for Interstitial Pneumonia Disease(ILD)"
MeLoD Co., Ltd.
l.r.igarashi@cme.co.jp
"Custom exosome production service"
Progenicyte Japan Co., Ltd.
ksugaya@progenicytejapan.com
"RRx-002, a novel small molecule agent for AKI"
Rev Therapeutics, Inc.
ysatoh@rev-therapeutics.com
"Development of innovative cancer immunotherapy harnessing PD-1 immune checkpoint inhibitors"
SCM BioMedica Co., Ltd.
gammadeltatanaka@yahoo.co.jp
"The best spinal implant for aging spine"
Spine Chronicle Japan
ryo_kitagawa@s-chronicle.co.jp
Commentators
Alan Donald (Matrix Medical Consulting, Inc.)
Jack Florio (IPL Capital Advisory )
Jeff Friedman (Friedman Bioventure)
Takashi Futami (AN Venture Partners)
Robert Hill (NuFund)
Jay Kunin (PharmaSecure, Inc. )
Kenneth Locke (Shanghai Pharma Biotherapeutics USA Inc.)
Daniel Maneval (Selva Therapeutics)
Charles Prussak (UC San Diego)
Prasad Sunkara (Seed to Fruit Ventures LLC.)
Takaaki Tobaru (Remiges Ventures)
Julio de Unamuno (HomeLab at UC San Diego)
Santosh Vetticaden (NuFund)
Leah Villegas (Aquillius Ventures)
Sponsors
